Plenary Session III Featured
9:00 AM - 10:25 AM CST
Saturday, January 16
During this session, we will explore the new hope for extending the indications for neuromodulation to new frontiers. In many cases, these breakthrough areas in neuromodulation are being funded by large investments by the NIH and other agencies. Key opinion leaders will review innovative new research and clinical trials being conducted in respiratory, and cardiac function.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Describe key progress in the field of neuromodulation for cardiac function.
- Identify indications for neuromodulation for respiratory function and its impact on functional and quality of life.
- Discuss ways to counteract and prevent racism and bias in medicine.
Welcome
David A. Provenzano, MD
Introduction of Honored Guest Lecturer
David A. Provenzano, MD
Honored Guest Lecturer: Fighting Bias and Racism in Medicine by Enhancing Diversity
Quinn Capers IV, MD
Neuromodulation and Obstructive Sleep Apnea
David T. Kent, MD
Neurocardiology and Neuromodulation
Kalyanam Shivkumar, MD PhD
Research on Off-Label Use for New And/Or Orphan Indications in Neuromodulation
Elias Veizi, MD PhD
Live Q&A Discussion
Faculty and Presentations subject to change.
Tagged under
- Faculty:
- Moderators: